{"id":"W4206710181","doi":"10.1016/j.euo.2021.12.007","title":"Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomy","year":2022,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Pembrolizumab; Pazopanib; Internal medicine; Renal cell carcinoma; Hazard ratio; Kidney cancer; Adverse effect; Oncology; Placebo; Nephrectomy; Adjuvant; Confidence interval; Cancer; Kidney; Sunitinib; Immunotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004053274,0.0001536699,0.0006723528,0.0001151675,0.0001607566,0.0004021974,0.0001110671,0.0002224484,0.001327151],"category_scores_gemma":[0.001351277,0.00006266871,0.0005246531,0.0001870984,0.00009578092,0.0003825362,0.0001336088,0.0006509642,0.000102444],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003337255,"about_ca_system_score_gemma":0.0005156393,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007840651,"about_ca_topic_score_gemma":0.002907594,"domain_scores_codex":[0.9998497,0.00004983451,0.00001428875,0.00002510278,0.00002183734,0.00003923496],"domain_scores_gemma":[0.9996799,0.0001293961,0.00006742512,0.00001239713,0.00001798122,0.00009287219],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1449829,0.001970355,0.1739161,0.001099418,0.002405426,0.0009019549,0.0001839329,0.004101609,0.02297922,0.0008632424,0.00459242,0.6420034],"study_design_scores_gemma":[0.007712668,0.03595226,0.9187431,0.0003666689,0.004126957,0.002300466,0.0003363859,0.005284042,0.005472758,0.001561459,0.01809035,0.00005294031],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9752873,0.02025169,0.0002676851,0.001188943,0.0001916415,0.00002529908,0.0001261752,0.00001265901,0.002648645],"genre_scores_gemma":[0.9960623,0.002789282,0.0001933886,0.0002586616,0.0001097373,0.000008698067,0.000170462,0.000003272094,0.0004042173],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001327151,"threshold_uncertainty_score":0.004439771,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006648434148015535,"score_gpt":0.2094829070434465,"score_spread":0.2028344728954309,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}